| Name | NWP-0476 |
|---|
| Description | NWP-0476 is BCL-2/BCL-xL inhibitor. NWP-0476 has a modified structure with fine-tuned BCL-xL activity. NWP-0476 can be used for relapsed T-acute lymphoblastic leukemia (T-ALL) research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C47H53ClN8O8S |
|---|---|
| Molecular Weight | 925.49 |